The use of autologous schwann cells to supplement sciatic nerve repair with a large gap: First in human experience

Allan D Levi, S. Shelby Burks, Kimberly D Anderson, Marine Dididze, Aisha Khan, W. Dalton Dietrich

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Insufficient donor nerve graft material in peripheral nerve surgery remains an obstacle for successful long-distance regeneration. Schwann cells (SCs) can be isolated from adult mammalian peripheral nerve biopsies and can be grown in culture and retain their capacity to enhance peripheral nerve regeneration within tubular repair strategies in multiple animal models. Human Schwann cells (hSCs) can be isolated, expanded in number, and retain their ability to promote regeneration and myelinate axons, but have never been tested in a clinical case of peripheral nerve injury. A sural nerve biopsy and peripheral nerve tissue from the traumatized sciatic nerve stumps was obtained after Food and Drug Administration (FDA) and Institutional Review Board (IRB) approval as well as patient consent. The SCs were isolated after enzymatic digestion of the nerve and expanded with the use of heregulin β1 (0.1 μg/ml) and forskolin (15 mM). After two passages the Schwann cell isolates were combined with sural nerve grafts to repair a large sciatic nerve defect (7.5 cm) after a traumatic nerve injury. The sural nerve and the traumatized sciatic nerve ends both served as an excellent source of purified (90% and 97%, respectively) hSCs. Using ultrasound and magnetic resonance imaging (MRI) we were able to determine continuity of the nerve graft repair and the absence of tumor formation. The patient had evidence of proximal sensory recovery and definitive motor recovery distal to the repair in the distribution of the tibial and common peroneal nerve. The patient did experience an improvement in her pain scores over time. The goals of this approach were to determine the safety and clinical feasibility of implementing a new cellular repair strategy. In summary, this approach represents a novel strategy in the treatment of peripheral nerve injury and represents the first reported use of autologous cultured SCs after human peripheral nerve injury.

Original languageEnglish (US)
Pages (from-to)1395-1403
Number of pages9
JournalCell Transplantation
Volume25
Issue number7
DOIs
StatePublished - 2016

Fingerprint

Schwann Cells
Sciatic Nerve
Repair
Peripheral Nerves
Peripheral Nerve Injuries
Sural Nerve
Cells
Grafts
Biopsy
Transplants
Regeneration
Recovery
Neuregulin-1
Nerve Tissue
Magnetic resonance
Peroneal Nerve
Nerve Regeneration
Aptitude
Research Ethics Committees
Surgery

Keywords

  • Nerve injury
  • Repair
  • Sciatic nerve
  • Sural nerve

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

The use of autologous schwann cells to supplement sciatic nerve repair with a large gap : First in human experience. / Levi, Allan D; Burks, S. Shelby; Anderson, Kimberly D; Dididze, Marine; Khan, Aisha; Dalton Dietrich, W.

In: Cell Transplantation, Vol. 25, No. 7, 2016, p. 1395-1403.

Research output: Contribution to journalArticle

Levi, Allan D ; Burks, S. Shelby ; Anderson, Kimberly D ; Dididze, Marine ; Khan, Aisha ; Dalton Dietrich, W. / The use of autologous schwann cells to supplement sciatic nerve repair with a large gap : First in human experience. In: Cell Transplantation. 2016 ; Vol. 25, No. 7. pp. 1395-1403.
@article{94ba23667c644f31b7460875d18fedfc,
title = "The use of autologous schwann cells to supplement sciatic nerve repair with a large gap: First in human experience",
abstract = "Insufficient donor nerve graft material in peripheral nerve surgery remains an obstacle for successful long-distance regeneration. Schwann cells (SCs) can be isolated from adult mammalian peripheral nerve biopsies and can be grown in culture and retain their capacity to enhance peripheral nerve regeneration within tubular repair strategies in multiple animal models. Human Schwann cells (hSCs) can be isolated, expanded in number, and retain their ability to promote regeneration and myelinate axons, but have never been tested in a clinical case of peripheral nerve injury. A sural nerve biopsy and peripheral nerve tissue from the traumatized sciatic nerve stumps was obtained after Food and Drug Administration (FDA) and Institutional Review Board (IRB) approval as well as patient consent. The SCs were isolated after enzymatic digestion of the nerve and expanded with the use of heregulin β1 (0.1 μg/ml) and forskolin (15 mM). After two passages the Schwann cell isolates were combined with sural nerve grafts to repair a large sciatic nerve defect (7.5 cm) after a traumatic nerve injury. The sural nerve and the traumatized sciatic nerve ends both served as an excellent source of purified (90{\%} and 97{\%}, respectively) hSCs. Using ultrasound and magnetic resonance imaging (MRI) we were able to determine continuity of the nerve graft repair and the absence of tumor formation. The patient had evidence of proximal sensory recovery and definitive motor recovery distal to the repair in the distribution of the tibial and common peroneal nerve. The patient did experience an improvement in her pain scores over time. The goals of this approach were to determine the safety and clinical feasibility of implementing a new cellular repair strategy. In summary, this approach represents a novel strategy in the treatment of peripheral nerve injury and represents the first reported use of autologous cultured SCs after human peripheral nerve injury.",
keywords = "Nerve injury, Repair, Sciatic nerve, Sural nerve",
author = "Levi, {Allan D} and Burks, {S. Shelby} and Anderson, {Kimberly D} and Marine Dididze and Aisha Khan and {Dalton Dietrich}, W.",
year = "2016",
doi = "10.3727/096368915X690198",
language = "English (US)",
volume = "25",
pages = "1395--1403",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "7",

}

TY - JOUR

T1 - The use of autologous schwann cells to supplement sciatic nerve repair with a large gap

T2 - First in human experience

AU - Levi, Allan D

AU - Burks, S. Shelby

AU - Anderson, Kimberly D

AU - Dididze, Marine

AU - Khan, Aisha

AU - Dalton Dietrich, W.

PY - 2016

Y1 - 2016

N2 - Insufficient donor nerve graft material in peripheral nerve surgery remains an obstacle for successful long-distance regeneration. Schwann cells (SCs) can be isolated from adult mammalian peripheral nerve biopsies and can be grown in culture and retain their capacity to enhance peripheral nerve regeneration within tubular repair strategies in multiple animal models. Human Schwann cells (hSCs) can be isolated, expanded in number, and retain their ability to promote regeneration and myelinate axons, but have never been tested in a clinical case of peripheral nerve injury. A sural nerve biopsy and peripheral nerve tissue from the traumatized sciatic nerve stumps was obtained after Food and Drug Administration (FDA) and Institutional Review Board (IRB) approval as well as patient consent. The SCs were isolated after enzymatic digestion of the nerve and expanded with the use of heregulin β1 (0.1 μg/ml) and forskolin (15 mM). After two passages the Schwann cell isolates were combined with sural nerve grafts to repair a large sciatic nerve defect (7.5 cm) after a traumatic nerve injury. The sural nerve and the traumatized sciatic nerve ends both served as an excellent source of purified (90% and 97%, respectively) hSCs. Using ultrasound and magnetic resonance imaging (MRI) we were able to determine continuity of the nerve graft repair and the absence of tumor formation. The patient had evidence of proximal sensory recovery and definitive motor recovery distal to the repair in the distribution of the tibial and common peroneal nerve. The patient did experience an improvement in her pain scores over time. The goals of this approach were to determine the safety and clinical feasibility of implementing a new cellular repair strategy. In summary, this approach represents a novel strategy in the treatment of peripheral nerve injury and represents the first reported use of autologous cultured SCs after human peripheral nerve injury.

AB - Insufficient donor nerve graft material in peripheral nerve surgery remains an obstacle for successful long-distance regeneration. Schwann cells (SCs) can be isolated from adult mammalian peripheral nerve biopsies and can be grown in culture and retain their capacity to enhance peripheral nerve regeneration within tubular repair strategies in multiple animal models. Human Schwann cells (hSCs) can be isolated, expanded in number, and retain their ability to promote regeneration and myelinate axons, but have never been tested in a clinical case of peripheral nerve injury. A sural nerve biopsy and peripheral nerve tissue from the traumatized sciatic nerve stumps was obtained after Food and Drug Administration (FDA) and Institutional Review Board (IRB) approval as well as patient consent. The SCs were isolated after enzymatic digestion of the nerve and expanded with the use of heregulin β1 (0.1 μg/ml) and forskolin (15 mM). After two passages the Schwann cell isolates were combined with sural nerve grafts to repair a large sciatic nerve defect (7.5 cm) after a traumatic nerve injury. The sural nerve and the traumatized sciatic nerve ends both served as an excellent source of purified (90% and 97%, respectively) hSCs. Using ultrasound and magnetic resonance imaging (MRI) we were able to determine continuity of the nerve graft repair and the absence of tumor formation. The patient had evidence of proximal sensory recovery and definitive motor recovery distal to the repair in the distribution of the tibial and common peroneal nerve. The patient did experience an improvement in her pain scores over time. The goals of this approach were to determine the safety and clinical feasibility of implementing a new cellular repair strategy. In summary, this approach represents a novel strategy in the treatment of peripheral nerve injury and represents the first reported use of autologous cultured SCs after human peripheral nerve injury.

KW - Nerve injury

KW - Repair

KW - Sciatic nerve

KW - Sural nerve

UR - http://www.scopus.com/inward/record.url?scp=84978064499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978064499&partnerID=8YFLogxK

U2 - 10.3727/096368915X690198

DO - 10.3727/096368915X690198

M3 - Article

C2 - 26610173

AN - SCOPUS:84978064499

VL - 25

SP - 1395

EP - 1403

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 7

ER -